Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock

Dow Jones

03/24

By Adria Calatayud

Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros ($369.3 million).

Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday.

Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year.

Bloomberg first reported the stock sale.

Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive.

Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets.

The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that it had begun winding down its funds and returning capital to its limited partners.

Write to Adria Calatayud at adria.calatayud@wsj.com

(END) Dow Jones Newswires

March 24, 2026 08:22 ET (12:22 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2621064004"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2621064004\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2621064004?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621064004","market":"nz","top_or_hot":-1,"title":"Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adria Calatayud \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros ($369.3 million). \n</p>\n<p>\n  Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday. \n</p>\n<p>\n  Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year. \n</p>\n<p>\n  Bloomberg first reported the stock sale. \n</p>\n<p>\n  Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive. \n</p>\n<p>\n  Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets. \n</p>\n<p>\n  The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that it had begun winding down its funds and returning capital to its limited partners. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 24, 2026 08:22 ET (12:22 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-03-24 20:22</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adria Calatayud \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros ($369.3 million). \n</p>\n<p>\n  Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday. \n</p>\n<p>\n  Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year. \n</p>\n<p>\n  Bloomberg first reported the stock sale. \n</p>\n<p>\n  Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive. \n</p>\n<p>\n  Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets. \n</p>\n<p>\n  The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that it had begun winding down its funds and returning capital to its limited partners. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 24, 2026 08:22 ET (12:22 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2621064004","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621064004","pubTimestamp":1774354920,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros .Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday.Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year.Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive.Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets.The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G.","BK4007":"制药"},"translate_title":"杰夫·乌本(Jeff Ubben)的Inclusive Capital出售价值3.69亿美元的拜耳股票","themeId":"8603dabb40994e59ac78c04c930c0d49","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"By Adria Calatayud \n\n\n \n\n\n  Investment firm Inclusive Capital, founded by activist investor Jeff Ubben, is selling a stake in Bayer for 318 million euros ($369.3 million). \n\n\n  Inclusive Capital sold around 8.5 million shares in the German agricultural and pharmaceutical company, representing a 0.9% stake, according to terms of the sale seen by Dow Jones Newswires. The shares were sold at 37.45 euros each, according to the deal terms. Bayer's shares closed at 38.47 euros on Monday. \n\n\n  Shares in Bayer were down 2.1% at 37.67 euros in European midday trading Tuesday, having fallen as much as 3.7% earlier. The stock is up 56% over the past year. \n\n\n  Bloomberg first reported the stock sale. \n\n\n  Ubben's firm took a stake in Bayer in early 2023 and pushed the company to hire an external candidate as its chief executive. \n\n\n  Bayer appointed Ubben to its supervisory board in 2024 with a mandate until 2028, citing his experience in financial and capital markets. \n\n\n  The Wall Street Journal reported in 2023 that Ubben was shutting down his social investing-focused firm, Inclusive Capital Partners, and that it had begun winding down its funds and returning capital to its limited partners. \n\n\n \n\n\n  Write to Adria Calatayud at adria.calatayud@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 08:22 ET (12:22 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}